Insulin-like growth factor-I (IGF-I) infusion into hypophysectomized or protein-deprived rats induces specific IGF-binding proteins in serum
- PMID: 2479531
- DOI: 10.1210/endo-125-6-2967
Insulin-like growth factor-I (IGF-I) infusion into hypophysectomized or protein-deprived rats induces specific IGF-binding proteins in serum
Abstract
The insulin-like growth factors (IGFs) are small peptides that are present in serum and extracellular fluids and stimulate the growth of many cell types. In extracellular fluids the IGFs are bound to carrier proteins that are believed to modify the biological actions of the IGFs. At least three structurally distinct IGF-binding proteins (IGF-BPs) have been identified, and the serum concentrations of one of these has been shown to be regulated by pituitary GH. We report here that this GH responsive protein [39,000-45,000 mol wt (Mr)] can be induced (7-fold) by infusion of IGF-I in hypophysectomized rats or (3.5-fold) in protein-deprived rats, whereas two other forms of IGF-BP (e.g. 31,000-34,000 and 24,000 Mr) showed no change in the hypophysectomized animals and minimal increases in the protein-deprived animals. Likewise, GH injections in hypophysectomized animals resulted in a 7-fold increase in the 39,000-45,000 Mr form and no change in the 31,000-34,000 and 24,000 Mr forms. The protein-deprived animals showed a 3.2-fold increase in the 39,000-45,000 Mr and 2.4- to 1.8-fold increases in the 31,000-34,000 and 24,000 Mr forms, respectively. Changes in the larger Mr IGF-BP in these experimental models are paralleled by changes in serum IGF-I, suggesting that the GH dependence of the former protein is mediated at least partially via IGF-I. Our findings also suggest that the secretion of IGF-I and at least one IGF-BP may be linked, providing a mechanism by which their extracellular fluid concentrations are coordinated. Because IGF-BPs are present in extracellular fluids and can modulate IGF-I-receptor interaction, induction of this protein may be an important mediator of IGF action.
Similar articles
-
Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.Endocrinology. 1992 Jun;130(6):3257-64. doi: 10.1210/endo.130.6.1375898. Endocrinology. 1992. PMID: 1375898
-
The interrelationship of growth hormone (GH), liver membrane GH receptor, serum GH-binding protein activity, and insulin-like growth factor I in the male rat.Endocrinology. 1990 Apr;126(4):1914-20. doi: 10.1210/endo-126-4-1914. Endocrinology. 1990. PMID: 2318149
-
Preferential measurement of insulin-like growth factor (IGF) I-related peptides in serum with the aid of IGF-binding proteins (IGF BPs) produced by rat liver in culture. Estimation of serum IGF BP levels.J Clin Endocrinol Metab. 1984 Sep;59(3):453-62. doi: 10.1210/jcem-59-3-453. J Clin Endocrinol Metab. 1984. PMID: 6205015
-
Growth hormone and the insulin-like growth factor system in myogenesis.Endocr Rev. 1996 Oct;17(5):481-517. doi: 10.1210/edrv-17-5-481. Endocr Rev. 1996. PMID: 8897022 Review.
-
Growth promotion by insulin-like growth factor I in hypophysectomized and diabetic rats.Mol Cell Endocrinol. 1998 May 25;140(1-2):143-9. doi: 10.1016/s0303-7207(98)00042-2. Mol Cell Endocrinol. 1998. PMID: 9722182 Review.
Cited by
-
Insulin-like growth factors in the peripheral nervous system.Endocrinology. 2008 Dec;149(12):5963-71. doi: 10.1210/en.2008-1020. Epub 2008 Aug 21. Endocrinology. 2008. PMID: 18719018 Free PMC article. Review.
-
Metabolic effects of recombinant human insulin-like growth factor-I in humans: comparison with recombinant human growth hormone.Pediatr Nephrol. 1996 Jun;10(3):318-23. doi: 10.1007/BF00866769. Pediatr Nephrol. 1996. PMID: 8792396 Review.
-
Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.J Clin Invest. 1993 Dec;92(6):2620-5. doi: 10.1172/JCI116877. J Clin Invest. 1993. PMID: 7504689 Free PMC article.
-
Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.J Clin Invest. 1993 Feb;91(2):391-6. doi: 10.1172/JCI116212. J Clin Invest. 1993. PMID: 7679407 Free PMC article.
-
Replicated selection for insulin-like growth factor-1 and body weight in mice.Theor Appl Genet. 1991 May;81(5):685-92. doi: 10.1007/BF00226738. Theor Appl Genet. 1991. PMID: 24221387
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources